China Resources Pharmaceutical Group Limited
CRPGF
$0.5414
$0.54140.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -0.48% | -71.03% | -0.86% | 123.41% | 0.31% |
| Total Depreciation and Amortization | -0.48% | 7.41% | -0.86% | 0.15% | 0.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -0.31% |
| Total Other Non-Cash Items | -0.48% | -11.13% | -0.86% | 34.33% | 0.31% |
| Change in Net Operating Assets | -0.48% | 231.30% | 0.86% | -171.72% | 0.31% |
| Cash from Operations | -0.48% | 1,940.44% | 0.86% | -105.31% | 0.31% |
| Capital Expenditure | 0.48% | -52.91% | 0.86% | 24.04% | -0.31% |
| Sale of Property, Plant, and Equipment | -0.48% | 105.23% | -0.86% | -60.68% | 0.31% |
| Cash Acquisitions | 0.48% | -338.64% | 0.86% | -14.30% | -0.31% |
| Divestitures | 0.50% | -- | -- | -- | 0.31% |
| Other Investing Activities | 0.48% | -16.55% | 0.86% | -156.92% | -0.31% |
| Cash from Investing | 0.48% | -58.65% | 0.86% | -48.92% | -0.31% |
| Total Debt Issued | 0.00% | -29.12% | 0.00% | 42.55% | 0.00% |
| Total Debt Repaid | 0.00% | -7.99% | 0.00% | 10.92% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.48% | -- | -- | -- | -0.31% |
| Other Financing Activities | 0.00% | -89.12% | 0.00% | -875.42% | 0.00% |
| Cash from Financing | 0.48% | -1,006.14% | -0.86% | 114.78% | -0.31% |
| Foreign Exchange rate Adjustments | 0.48% | -821.56% | -0.88% | 1,760.47% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.48% | -151.63% | 0.86% | -191.72% | 0.31% |